Clinical Trial: A Non-Interventional Study of Clinical Characteristics and Mortality of US Patients With Fibrodysplasia Ossificans Progressiva (FOP)
Study Status: COMPLETED
Recruit Status: COMPLETED
Study Type: OBSERVATIONAL
Official Title: Clinical Characteristics and Mortality in Patients With Fibrodysplasia Ossificans Progressiva (FOP): A Non-Interventional US National Retrospective Cohort
Brief Summary:
Primary Objective(s):
- To describe the demographic characteristics of people living with FOP
- To describe the prevalence of clinical characteristics of interest in people living with FOP
- To describe the use of key medications in people living with FOP
- To estimate the crude mortality rate among people with FOP
Detailed Summary:
Sponsor: Regeneron Pharmaceuticals
Current Primary Outcome:
Original Primary Outcome:
Current Secondary Outcome:
Original Secondary Outcome:
Information By: Regeneron Pharmaceuticals
Dates:
Date Received: September 11, 2023
Date Started: June 29, 2023
Date Completion: June 29, 2023
Last Updated: October 24, 2023
Last Verified: October 01, 2023